{
  "doc_id": "Carnitine-Palmitoyltransferase-1A-Deficiency",
  "doc_filename": "Carnitine-Palmitoyltransferase-1A-Deficiency.pdf",
  "top_entities": [
    {
      "name": "CPT1A deficiency",
      "mention_count": 2,
      "entity_type": "disease"
    },
    {
      "name": "acute fatty liver of pregnancy",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "carnitine",
      "mention_count": 1,
      "entity_type": "drug"
    },
    {
      "name": "Ammonia",
      "mention_count": 1,
      "entity_type": "drug"
    },
    {
      "name": "CPT1A",
      "mention_count": 1,
      "entity_type": "gene"
    },
    {
      "name": "CBLIF",
      "mention_count": 1,
      "entity_type": "gene"
    }
  ],
  "file_size_bytes": 2671,
  "file_size_human": "2.6 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:18",
  "doi": null,
  "doi_url": null,
  "document_type_code": "CRM",
  "document_type_name": "Clinical Research Materials",
  "document_type_group": "Clinical Research Materials",
  "classification_confidence": 0.15,
  "title": "Carnitine Palmitoyltransferase 1A Deficiency: Clinical Overview and Diagnostic Guidelines",
  "short_description": "Clinical document describing CPT1A deficiency, a rare autosomal recessive disorder affecting fatty acid metabolism and causing liver dysfunction, hypoglycemia, and neurological complications.",
  "long_description": "This clinical reference document provides a comprehensive overview of Carnitine Palmitoyltransferase 1A (CPT1A) deficiency, a rare genetic metabolic disorder caused by mutations in the CPT1A gene. The document details the three recognized types of the condition: hepatic encephalopathy type in children, adult-onset myopathy type, and acute fatty liver of pregnancy. It covers the pathophysiology involving impaired long-chain fatty acid metabolism, clinical presentations including liver failure and hypoglycemia, population demographics showing higher incidence in Hutterite and Inuit populations, and diagnostic approaches including enzyme testing, molecular genetic analysis, and newborn screening protocols. The document serves as a clinical reference for healthcare providers managing patients with suspected or confirmed CPT1A deficiency.",
  "document_date": "2026-01-07T22:25:18",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T03:19:59.625441"
}